Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
47.87
+0.02 (0.04%)
At close: Oct 10, 2025, 4:00 PM EDT
47.88
+0.01 (0.02%)
After-hours: Oct 10, 2025, 7:50 PM EDT

Tourmaline Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
22.6822.7513.042.1813.267.41
Research & Development
79.7766.9932.3717.5334.2515.28
Total Operating Expenses
102.4589.7345.4119.747.5122.68
Operating Income
-102.45-89.73-45.41-19.7-47.51-22.68
Total Non-Operating Income (Expense)
13.9816.523.29--0.33-0.02
Pretax Income
-88.47-73.21-42.12-19.7-47.83-22.71
Net Income
-88.47-73.21-42.12-19.7-47.83-22.71
Net Income to Common
-88.47-73.21-42.12-19.7-47.83-22.71
Shares Outstanding (Basic)
26255131
Shares Outstanding (Diluted)
26255131
Shares Change (YoY)
53.99%433.98%441.28%-69.89%335.69%-
EPS (Basic)
-3.44-2.89-8.87-22.46-16.40-34.00
EPS (Diluted)
-3.44-2.89-8.87-22.46-16.40-34.00
Free Cash Flow
-86.28-77.27-28.14-6.53-42.43-20.5
Free Cash Flow Per Share
-3.35-3.05-5.93-7.44-14.57-30.66
EBITDA
-102.41-89.69-45.38-19.7-46.88-22.24
EBIT
-102.45-89.73-45.41-19.7-47.51-22.68
Updated Aug 13, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q